SCHEMBL9049386

SCHEMBL9049386

O=C(Nc1nc2ccccc2s1)C1CCc2[nH]cnc2C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.49
CYP2C19 P33261 2/20 0.49
GAA P10253 2/20 0.49
NPC1 O15118 7/20 0.48
RAB9A P51151 7/20 0.48
SMN1; SMN2 Q16637 5/20 0.48
ALDH1A1 P00352 3/20 0.48
TP53 P04637 2/20 0.48
MAPK1 P28482 2/20 0.48
MEN1 O00255 8/20 0.47
KMT2A Q03164 8/20 0.47
NFKB1 P19838 4/20 0.47
NFKB2 Q00653 4/20 0.47
RELA Q04206 4/20 0.47
CNR1 P21554 1/20 0.47
MAPT P10636 5/20 0.46
LMNA P02545 2/20 0.46
ADORA1 P30542 2/20 0.46
DYRK1A Q13627 1/20 0.46
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6851321 0.79 HPGD (0.48) GAANPC1RAB9ASMN1; SMN2MEN1
SCHEMBL9050232 0.79 SMN1; SMN2 (0.63) CYP1A2NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL9050448 0.78 TRPV1 (0.47) NPC1RAB9ASMN1; SMN2ALDH1A1TP53
SCHEMBL880500 0.77 GAA (0.76) CYP1A2CYP2C19GAANPC1RAB9A
SCHEMBL9581806 0.76 SMN1; SMN2 (0.50) NPC1RAB9ASMN1; SMN2ALDH1A1TP53
SCHEMBL7325548 0.76 SMN1; SMN2 (0.45) GAANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7327986 0.76 L3MBTL1 (0.47) GAANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL9050178 0.76 KMT2A (0.52) GAANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL6227837 0.75 GAA (0.68) CYP1A2CYP2C19GAANPC1RAB9A
Fumaric Acid SCHEMBL7334141 0.75 HPGD (0.43) GAANPC1RAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0381422-B1 Tetrahydrobenzimidazole derivatives YAMANOUCHI PHARMA CO LTD (JP) 1996-10-23 EP disclosed
US-5496942-A 5-HT3-RECEPTOR ANTAGONISTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1996-03-05 US disclosed
US-5344927-A 5-HT3 antagonist YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1994-09-06 US disclosed
EP-0381422-A1 Tetrahydrobenzimidazole derivatives YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1990-08-08 EP disclosed